Taiko Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	3,788	4,532	5,484	3,105	5,796	4,944
Short-Term Investments	-	-	-	400	302	-
Cash & Short-Term Investments	3,788	4,532	5,484	3,505	6,098	4,944
Cash Growth	-20.65%	-17.36%	56.46%	-42.52%	23.34%	-50.09%
Receivables	2,020	2,428	1,985	1,798	4,056	7,918
Inventory	1,966	1,675	1,373	1,952	3,205	6,408
Other Current Assets	416	126	267	301	424	552
Total Current Assets	8,190	8,761	9,109	7,556	13,783	19,822
Property, Plant & Equipment	3,305	3,271	3,581	6,397	7,113	9,446
Long-Term Investments	362	747	526	867	1,338	1,564
Other Intangible Assets	25	27	1	222	299	319
Long-Term Deferred Tax Assets	-	105	1	2	-	605
Other Long-Term Assets	2	3	2	2	2	1
Total Assets	11,884	12,914	13,220	15,046	22,535	31,757
Accounts Payable	839	338	375	274	309	2,928
Accrued Expenses	180	176	75	23	149	513
Current Portion of Long-Term Debt	996	1,206	1,206	1,039	923	-
Current Portion of Leases	-	18	27	29	36	31
Current Income Taxes Payable	14	728	782	571	1,282	3,181
Other Current Liabilities	292	389	581	857	1,621	834
Total Current Liabilities	2,321	2,855	3,046	2,793	4,320	7,487
Long-Term Debt	27	792	1,999	2,720	3,760	-
Long-Term Leases	-	11	22	21	54	63
Pension & Post-Retirement Benefits	701	655	624	659	805	742
Long-Term Deferred Tax Liabilities	-	20	188	125	104	-
Other Long-Term Liabilities	599	618	603	685	686	685
Total Liabilities	3,648	4,951	6,482	7,003	9,729	8,977
Common Stock	10	10	2,267	1,201	1,201	1,148
Additional Paid-In Capital	4,978	4,997	2,689	1,642	1,648	1,516
Retained Earnings	3,196	2,526	1,628	5,239	10,134	20,509
Treasury Stock	-237	-273	-300	-348	-388	-480
Comprehensive Income & Other	289	703	454	309	211	87
Shareholders' Equity	8,236	7,963	6,738	8,043	12,806	22,780
Total Liabilities & Equity	11,884	12,914	13,220	15,046	22,535	31,757
Total Debt	1,023	2,027	3,254	3,809	4,773	94
Net Cash (Debt)	2,765	2,505	2,230	-304	1,325	4,850
Net Cash Growth	8.69%	12.33%	-	-	-72.68%	-50.66%
Net Cash Per Share	55.06	49.92	47.09	-6.97	30.45	111.86
Filing Date Shares Outstanding	50.25	50.19	50.15	43.58	43.58	43.33
Total Common Shares Outstanding	50.25	50.19	49.95	43.58	43.58	43.32
Working Capital	5,869	5,906	6,063	4,763	9,463	12,335
Book Value Per Share	163.90	158.65	134.90	184.57	293.84	525.90
Tangible Book Value	8,211	7,936	6,737	7,821	12,507	22,461
Tangible Book Value Per Share	163.40	158.11	134.88	179.48	286.98	518.54

Source: S&P Global Market Intelligence. Standard template. Financial Sources.